section name header

Information

AHFS Class:

76:00 Oxytocics

Generic Name

Products

Oxytocin is available as a 10-unit/mL injection solution in 1-mL single-dose vials, 10- or 30-mL multiple-dose vials, and 50-mL pharmacy bulk packages.2856; 2857; 2858 Each mL contains oxytocin 10 units with chlorobutanol 0.5% as a preservative.2856; 2857; 2858 Acetic acid may have been added for pH adjustment.2856; 2857; 2858 Some products may contain acetic acid and ammonium acetate as buffers.2856; 2857

Units

One unit of oxytocin is equivalent to 2 to 2.2 mcg of pure oxytocin.4

pH

3.52856; 2857 or from 3 to 5.2858

Trade Name(s)

Pitocin

Administration

Oxytocin is administered by intravenous infusion and, depending on the indication, may be administered by intramuscular injection.2856; 2857; 2858 For induction or stimulation of labor, oxytocin should be administered only by intravenous infusion2856; 2857; 2858 because the drug’s effects are unpredictable and difficult to control.4

For intravenous infusion for induction or stimulation of labor, product labeling recommends oxytocin injection be diluted to a usual concentration of 10 milliunits/mL by adding 10 units (1 mL) to 1000 mL of Ringer’s injection, lactated, or sodium chloride 0.9%.2856; 2857; 2858 For other indications, product labeling states oxytocin may be diluted to a concentration of 20 milliunits/mL (1 mL in 500 mL) or up to 40 milliunits/mL in a compatible infusion solution.2856; 2857

Stability

Oxytocin injection is a clear, colorless solution.2856; 2857; 2858 Visually inspect solutions for particulate matter or discoloration prior to use.2856; 2857; 2858

Intact containers should be stored at controlled room temperature2856; 2857; 2858 and protected from freezing.2858 Discard unused portions of the drug.2857; 2858

Oxytocin appears to be rapidly decomposed in the presence of sodium bisulfite.333

Freezing Solutions

Oxytocin (Teva) 0.02 unit/mL in sodium chloride 0.9% in polyolefin bags (B. Braun) was physically stable with less than 10% loss of drug when frozen at -20°C for 30 days, thawed, and allowed to come to room temperature.4114

Filtration

Oxytocin (Parke-Davis) 25 units/100 mL in dextrose 5% and sodium chloride 0.9% was filtered at about 3 mL/min through a 0.22-µm cellulose ester membrane filter (Ivex-2). At this concentration, 25 times higher than normally used, oxytocin appeared to bind initially to the filter from the sodium chloride 0.9% solution. Results in dextrose 5% were equivocal. From these data, it is not possible to draw a definite conclusion regarding substantial binding of oxytocin during normal usage.533

Standardize 4 Safety

One or more standardized concentrations for this drug have been established through Standardize 4 Safety (S4S), a national patient safety initiative to reduce medication errors, especially during transitions of care. (See Standardize 4 Safety in Users Guide.) Recommendations developed to date through this initiative are available at www.ashp.org/pharmacy-practice/standardize-4-safety-initiative.

Oxytocin

Table 1. Standardize 4 Safety Continuous IV Infusion Standard Concentrations for Oxytocin3636

Patient PopulationConcentration StandardsDosing Units
Adultsa0.06 units/mLmilliunits/minute (note dosing units differ from concentration units)

aSee ISMP for best practices. www.ismp.org/resources/taking-closer-look-medication-errors-involve-oxytocin; www.ncbi.nlm.nih.gov/pmc/articles/PMC3956395/

Compatibility

Solution Compatibility

Additive Compatibility

Drugs in Syringe Compatibility

Y-Site Injection Compatibility (1:1 Mixture)

Other Info

References

For a list of references cited in the text of this monograph, search the monograph titled References.

Copyrights

ASHP® Injectable Drug InformationTM. Selected Revisions September 12, 2025. © Copyright, 2025. American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.